Veterinary Vaccines Global Market Outlook - Trends, Forecast, and Opportunity Assessment (2014-2022)

Veterinary Vaccines Global Market Outlook - Trends, Forecast, and Opportunity Assessment (2014-2022)

  • Published: October 2015
  • ID: SMRC15224

The Global Veterinary Vaccines Market accounted for $5.3 billion in 2014 and is expected to grow at a CAGR of 6.2% to reach $8.6 billion by 2022. The factors driving the veterinary vaccines market include rising zoonotic diseases, growing incidence of animal diseases, increasing investments by government and welfare associations. However, factors such as increasing adoption of vegetarian food in prominent economies and increasing costs of storage and maintenance of vaccines are hindering the market growth. Growing awareness of animal health in emerging economies and technological innovations are likely to create opportunities for veterinary vaccines market in the coming years.

The Global veterinary vaccines market is segmented on the basis of diseases, technologies and geography. On the basis of diseases, the veterinary vaccine market is segmented into companion animal diseases (respiratory, gastrointestinal and reproductive tracts), poultry diseases (bronchitis, avian influenza, newcastle disease and marek's disease), porcine diseases (porcine reproductive disease, swine pneumonia and swine influenza) and equine diseases (rhinopneumonitis, influenza and encephalomyelitis). By technologies, the market is categorized into toxoid vaccines, DNA vaccines, recombinant vaccines, live attenuated vaccines (LAV) and inactivated vaccines. By geography, it is segmented into North America, Europe, Asia Pacific and Rest of the World. European region is known to be a leading veterinary vaccine market in terms of consumption, closely followed by the U.S.  However, Asia is expected to register a higher growth rate during the forecast period owing to huge investment opportunities in this region.

Some of the key players in the veterinary vaccine market include Zoetis (U.S.), Merck Animal Health (U.S.), Merial Inc. (Sanofi) (France), Elanco Animal Health (U.S.)., Boehringer Ingelheim (Germany), Bayer Healthcare (Germany), Bioniche Animal Health (Canada), Heska Co. (U.S.), Ceva Animal Health, Inc. and Virbac.

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 8 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

1 Executive Summary        
           
2 Preface         
 2.1 Abstract        
 2.2 Research Scope        
 2.3 Research Methodology       
 2.4 Research Sources       
           
3 Market Trend Analysis        
 3.1 Introduction        
 3.2 Drivers        
 3.3 Restraints        
 3.4 Opportunities        
 3.5 Threats        
           
4 Porters Five Force Analysis       
 4.1 Bargaining power of suppliers      
 4.2 Bargaining power of buyers       
 4.3 Threat of substitutes       
 4.4 Threat of new entrants       
 4.5 Competitive rivalry       
           
5  Global Veterinary Vaccines  Market, By Diseases     
 5.1 Introduction        
 5.2 Companion animal diseases      
  5.2.1 Respiratory diseases      
  5.2.2 Gastrointestinal  diseases      
  5.2.3 Reproductive  diseases      
 5.3 Poultry diseases        
  5.3.1 Bronchitis       
  5.3.2 Avian influenza       
  5.3.3 Newcastle disease       
  5.3.4 Marek's disease       
 5.4 Porcine diseases        
  5.4.1 Porcine reproductive disease       
  5.4.2 Swine pneumonia         
  5.4.3 Swine influenza        
 5.5 Equine diseases        
  5.5.1 Rhinopneumonitis       
  5.5.2 Influenza         
  5.5.3 Encephalomyelitis       
           
6  Global Veterinary Vaccines  Market, By Technologies     
 6.1 Introduction        
 6.2 Toxoid vaccines        
 6.3 DNA vaccines        
 6.4 Recombinant vaccines       
 6.5 Live attenuated vaccines        
 6.6 Inactivated vaccines       
           
7 Global Veterinary Vaccines  Market, By Geography     
 7.1 North America        
  7.1.1 US        
  7.1.2 Canada        
 7.2 Europe        
  7.2.1 Germany        
  7.2.2 France        
  7.2.3 Italy        
  7.2.4 UK        
  7.2.5 Spain        
 7.3 Asia Pacific        
  7.3.1 Japan        
  7.3.2 China        
  7.3.3 India        
  7.3.4 Australia        
  7.3.5 New Zealand       
  7.3.6 Rest of Asia       
 7.4 Rest of the World       
  7.4.1 Latin America       
  7.4.2 Middle East       
  7.4.3 Africa        
  7.4.4 Others        
           
8 Key Developments        
 8.1 Agreements, Partnerships, Collaborations and Joint Ventures   
 8.2 Acquisitions & Mergers       
 8.3 New Product Launch       
 8.4 Expansions        
 8.5 Other Key Strategies       
           
9 Company Profiling        
 9.1 Zoetis (U.S.)         
 9.2 Merck Animal Health (U.S.)       
 9.3 Merial Inc. (Sanofi) (France)      
 9.4 Elanco Animal Health (U.S.).      
 9.5 Boehringer Ingelheim (Germany)      
 9.6 Bayer Healthcare (Germany)      
 9.7 Bioniche Animal Health (Canada)      
 9.8 Heska Co. (U.S.)        
 9.9 Ceva Animal Health, Inc.        
 9.10 Virbac         
           
List of Tables         
1 Global Veterinary Vaccines Market Outlook, By Diseases (2012-2022) ($MN)   
2 Global Veterinary Vaccines Market Outlook, By Companion animal diseases (2012-2022) ($MN) 
3 Global Veterinary Vaccines Market Outlook, By Respiratory diseases (2012-2022) ($MN) 
4 Global Veterinary Vaccines Market Outlook, By Gastrointestinal  diseases (2012-2022) ($MN) 
5 Global Veterinary Vaccines Market Outlook, By Reproductive  diseases (2012-2022) ($MN) 
6 Global Veterinary Vaccines Market Outlook, By Poultry diseases (2012-2022) ($MN)  
7 Global Veterinary Vaccines Market Outlook, By Bronchitis (2012-2022) ($MN)  
8 Global Veterinary Vaccines Market Outlook, By Avian influenza (2012-2022) ($MN)  
9 Global Veterinary Vaccines Market Outlook, By Newcastle disease (2012-2022) ($MN)  
10 Global Veterinary Vaccines Market Outlook, By Marek's disease  (2012-2022) ($MN)  
11 Global Veterinary Vaccines Market Outlook, By Porcine diseases  (2012-2022) ($MN)  
12 Global Veterinary Vaccines Market Outlook, By Porcine reproductive disease    (2012-2022) ($MN)
13 Global Veterinary Vaccines Market Outlook, By Swine pneumonia    (2012-2022) ($MN)   
14 Global Veterinary Vaccines Market Outlook, By Swine influenza  (2012-2022) ($MN)  
15 Global Veterinary Vaccines Market Outlook, By Equine diseases (2012-2022) ($MN)  
16 Global Veterinary Vaccines Market Outlook, By Rhinopneumonitis (2012-2022) ($MN)  
17 Global Veterinary Vaccines Market Outlook, By Influenza   (2012-2022) ($MN)  
18 Global Veterinary Vaccines Market Outlook, By Encephalomyelitis (2012-2022) ($MN)  
19 Global Veterinary Vaccines Market Outlook, By Technologies (2012-2022) ($MN)   
20 Global Veterinary Vaccines Market Outlook, By Toxoid vaccines (2012-2022) ($MN)  
21 Global Veterinary Vaccines Market Outlook, By DNA vaccines (2012-2022) ($MN)  
22 Global Veterinary Vaccines Market Outlook, By Recombinant vaccines  (2012-2022) ($MN) 
23 Global Veterinary Vaccines Market Outlook, By Live attenuated vaccines   (2012-2022) ($MN) 
24 Global Veterinary Vaccines Market Outlook, By Inactivated vaccines (2012-2022) ($MN)  
25 North America Veterinary Vaccines Market Outlook, By Diseases (2012-2022) ($MN)  
26 North America Veterinary Vaccines Market Outlook, By Companion animal diseases (2012-2022) ($MN)
27 North America Veterinary Vaccines Market Outlook, By Respiratory diseases (2012-2022) ($MN) 
28 North America Veterinary Vaccines Market Outlook, By Gastrointestinal  diseases (2012-2022) ($MN)
29 North America Veterinary Vaccines Market Outlook, By Reproductive  diseases (2012-2022) ($MN)
30 North America Veterinary Vaccines Market Outlook, By Poultry diseases (2012-2022) ($MN) 
31 North America Veterinary Vaccines Market Outlook, By Bronchitis (2012-2022) ($MN)  
32 North America Veterinary Vaccines Market Outlook, By Avian influenza (2012-2022) ($MN) 
33 North America Veterinary Vaccines Market Outlook, By Newcastle disease (2012-2022) ($MN) 
34 North America Veterinary Vaccines Market Outlook, By Marek's disease  (2012-2022) ($MN) 
35 North America Veterinary Vaccines Market Outlook, By Porcine diseases  (2012-2022) ($MN) 
36 North America Veterinary Vaccines Market Outlook, By Porcine reproductive disease    (2012-2022) ($MN)
37 North America Veterinary Vaccines Market Outlook, By Swine pneumonia    (2012-2022) ($MN) 
38 North America Veterinary Vaccines Market Outlook, By Swine influenza  (2012-2022) ($MN) 
39 North America Veterinary Vaccines Market Outlook, By Equine diseases (2012-2022) ($MN) 
40 North America Veterinary Vaccines Market Outlook, By Rhinopneumonitis (2012-2022) ($MN) 
41 North America Veterinary Vaccines Market Outlook, By Influenza   (2012-2022) ($MN)  
42 North America Veterinary Vaccines Market Outlook, By Encephalomyelitis (2012-2022) ($MN) 
43 North America Veterinary Vaccines Market Outlook, By Technologies (2012-2022) ($MN) 
44 North America Veterinary Vaccines Market Outlook, By Toxoid vaccines (2012-2022) ($MN) 
45 North America Veterinary Vaccines Market Outlook, By DNA vaccines (2012-2022) ($MN) 
46 North America Veterinary Vaccines Market Outlook, By Recombinant vaccines  (2012-2022) ($MN)
47 North America Veterinary Vaccines Market Outlook, By Live attenuated vaccines   (2012-2022) ($MN)
48 North America Veterinary Vaccines Market Outlook, By Inactivated vaccines (2012-2022) ($MN) 
49 Europe Veterinary Vaccines Market Outlook, By Diseases (2012-2022) ($MN)   
50 Europe Veterinary Vaccines Market Outlook, By Companion animal diseases (2012-2022) ($MN) 
51 Europe Veterinary Vaccines Market Outlook, By Respiratory diseases (2012-2022) ($MN) 
52 Europe Veterinary Vaccines Market Outlook, By Gastrointestinal  diseases (2012-2022) ($MN) 
53 Europe Veterinary Vaccines Market Outlook, By Reproductive  diseases (2012-2022) ($MN) 
54 Europe Veterinary Vaccines Market Outlook, By Poultry diseases (2012-2022) ($MN)  
55 Europe Veterinary Vaccines Market Outlook, By Bronchitis (2012-2022) ($MN)  
56 Europe Veterinary Vaccines Market Outlook, By Avian influenza (2012-2022) ($MN)  
57 Europe Veterinary Vaccines Market Outlook, By Newcastle disease (2012-2022) ($MN)  
58 Europe Veterinary Vaccines Market Outlook, By Marek's disease  (2012-2022) ($MN)  
59 Europe Veterinary Vaccines Market Outlook, By Porcine diseases  (2012-2022) ($MN)  
60 Europe Veterinary Vaccines Market Outlook, By Porcine reproductive disease    (2012-2022) ($MN)
61 Europe Veterinary Vaccines Market Outlook, By Swine pneumonia    (2012-2022) ($MN) 
62 Europe Veterinary Vaccines Market Outlook, By Swine influenza  (2012-2022) ($MN)  
63 Europe Veterinary Vaccines Market Outlook, By Equine diseases (2012-2022) ($MN)  
64 Europe Veterinary Vaccines Market Outlook, By Rhinopneumonitis (2012-2022) ($MN)  
65 Europe Veterinary Vaccines Market Outlook, By Influenza   (2012-2022) ($MN)  
66 Europe Veterinary Vaccines Market Outlook, By Encephalomyelitis (2012-2022) ($MN)  
67 Europe Veterinary Vaccines Market Outlook, By Technologies (2012-2022) ($MN)  
68 Europe Veterinary Vaccines Market Outlook, By Toxoid vaccines (2012-2022) ($MN)  
69 Europe Veterinary Vaccines Market Outlook, By DNA vaccines (2012-2022) ($MN)  
70 Europe Veterinary Vaccines Market Outlook, By Recombinant vaccines  (2012-2022) ($MN) 
71 Europe Veterinary Vaccines Market Outlook, By Live attenuated vaccines   (2012-2022) ($MN) 
72 Europe Veterinary Vaccines Market Outlook, By Inactivated vaccines (2012-2022) ($MN) 
73 Asia Pacific Veterinary Vaccines Market Outlook, By Diseases (2012-2022) ($MN)  
74 Asia Pacific Veterinary Vaccines Market Outlook, By Companion animal diseases (2012-2022) ($MN)
75 Asia Pacific Veterinary Vaccines Market Outlook, By Respiratory diseases (2012-2022) ($MN) 
76 Asia Pacific Veterinary Vaccines Market Outlook, By Gastrointestinal  diseases (2012-2022) ($MN) 
77 Asia Pacific Veterinary Vaccines Market Outlook, By Reproductive  diseases (2012-2022) ($MN) 
78 Asia Pacific Veterinary Vaccines Market Outlook, By Poultry diseases (2012-2022) ($MN) 
79 Asia Pacific Veterinary Vaccines Market Outlook, By Bronchitis (2012-2022) ($MN)  
80 Asia Pacific Veterinary Vaccines Market Outlook, By Avian influenza (2012-2022) ($MN) 
81 Asia Pacific Veterinary Vaccines Market Outlook, By Newcastle disease (2012-2022) ($MN) 
82 Asia Pacific Veterinary Vaccines Market Outlook, By Marek's disease  (2012-2022) ($MN) 
83 Asia Pacific Veterinary Vaccines Market Outlook, By Porcine diseases  (2012-2022) ($MN) 
84 Asia Pacific Veterinary Vaccines Market Outlook, By Porcine reproductive disease    (2012-2022) ($MN)
85 Asia Pacific Veterinary Vaccines Market Outlook, By Swine pneumonia    (2012-2022) ($MN) 
86 Asia Pacific Veterinary Vaccines Market Outlook, By Swine influenza  (2012-2022) ($MN) 
87 Asia Pacific Veterinary Vaccines Market Outlook, By Equine diseases (2012-2022) ($MN) 
88 Asia Pacific Veterinary Vaccines Market Outlook, By Rhinopneumonitis (2012-2022) ($MN) 
89 Asia Pacific Veterinary Vaccines Market Outlook, By Influenza   (2012-2022) ($MN)  
90 Asia Pacific Veterinary Vaccines Market Outlook, By Encephalomyelitis (2012-2022) ($MN) 
91 Asia Pacific Veterinary Vaccines Market Outlook, By Technologies (2012-2022) ($MN)  
92 Asia Pacific Veterinary Vaccines Market Outlook, By Toxoid vaccines (2012-2022) ($MN) 
93 Asia Pacific Veterinary Vaccines Market Outlook, By DNA vaccines (2012-2022) ($MN)  
94 Asia Pacific Veterinary Vaccines Market Outlook, By Recombinant vaccines  (2012-2022) ($MN) 
95 Asia Pacific Veterinary Vaccines Market Outlook, By Live attenuated vaccines   (2012-2022) ($MN) 
96 Asia Pacific Veterinary Vaccines Market Outlook, By Inactivated vaccines (2012-2022) ($MN) 
97 Rest Of The World Veterinary Vaccines Market Outlook, By Diseases (2012-2022) ($MN) 
98 Rest Of The World Veterinary Vaccines Market Outlook, By Companion animal diseases (2012-2022) ($MN)
99 Rest Of The World Veterinary Vaccines Market Outlook, By Respiratory diseases (2012-2022) ($MN)
100 Rest Of The World Veterinary Vaccines Market Outlook, By Gastrointestinal  diseases (2012-2022) ($MN)
101 Rest Of The World Veterinary Vaccines Market Outlook, By Reproductive  diseases (2012-2022) ($MN)
102 Rest Of The World Veterinary Vaccines Market Outlook, By Poultry diseases (2012-2022) ($MN) 
103 Rest Of The World Veterinary Vaccines Market Outlook, By Bronchitis (2012-2022) ($MN) 
104 Rest Of The World Veterinary Vaccines Market Outlook, By Avian influenza (2012-2022) ($MN) 
105 Rest Of The World Veterinary Vaccines Market Outlook, By Newcastle disease (2012-2022) ($MN) 
106 Rest Of The World Veterinary Vaccines Market Outlook, By Marek's disease  (2012-2022) ($MN) 
107 Rest Of The World Veterinary Vaccines Market Outlook, By Porcine diseases  (2012-2022) ($MN) 
108 Rest Of The World Veterinary Vaccines Market Outlook, By Porcine reproductive disease    (2012-2022) ($MN)
109 Rest Of The World Veterinary Vaccines Market Outlook, By Swine pneumonia    (2012-2022) ($MN)
110 Rest Of The World Veterinary Vaccines Market Outlook, By Swine influenza  (2012-2022) ($MN) 
111 Rest Of The World Veterinary Vaccines Market Outlook, By Equine diseases (2012-2022) ($MN) 
112 Rest Of The World Veterinary Vaccines Market Outlook, By Rhinopneumonitis (2012-2022) ($MN) 
113 Rest Of The World Veterinary Vaccines Market Outlook, By Influenza   (2012-2022) ($MN) 
114 Rest Of The World Veterinary Vaccines Market Outlook, By Encephalomyelitis (2012-2022) ($MN) 
115 Rest Of The World Veterinary Vaccines Market Outlook, By Technologies (2012-2022) ($MN) 
116 Rest Of The World Veterinary Vaccines Market Outlook, By Toxoid vaccines (2012-2022) ($MN) 
117 Rest Of The World Veterinary Vaccines Market Outlook, By DNA vaccines (2012-2022) ($MN) 
118 Rest Of The World Veterinary Vaccines Market Outlook, By Recombinant vaccines  (2012-2022) ($MN)
119 Rest Of The World Veterinary Vaccines Market Outlook, By Live attenuated vaccines   (2012-2022) ($MN)
120 Rest Of The World Veterinary Vaccines Market Outlook, By Inactivated vaccines (2012-2022) ($MN) 

1. What do I do if I have a query on this report?
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
2. Is the sample available for this report? Can I request the sample with my specific requirements?
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
3. Format of the report?
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
4. Services prior to purchase and after purchase?
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
5. License Type and Delivery?
We have 3 different licensing options available in electronic format.
  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment
6. Purchase procedure and Invoicing?
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards
7. Post sale support?
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Single User License (PDF)

 

2 - 5 User License (PDF)

 

Site License (PDF)

 

Corporate License (PDF)

 

Have a Question?


Know our Methodology

WHY CHOOSE US ?

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Adding more values to your product of interest.

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials